Anti-neoplastic action of Cimetidine/Vitamin C on histamine and the PI3K/AKT/mTOR pathway in Ehrlich breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Anti-neoplastic action of Cimetidine/Vitamin C on histamine and the PI3K/AKT/mTOR pathway in Ehrlich breast cancer ; volume:12 ; number:1 ; day:7 ; month:7 ; year:2022 ; pages:1-21 ; date:12.2022
Scientific reports ; 12, Heft 1 (7.7.2022), 1-21, 12.2022
- Creator
-
Ibrahim, Sherihan Salaheldin Abdelhamid
El-Aal, Sarah A. Abd
Reda, Ahmed M.
Achy, Samar El
Shahine, Yasmine
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-15551-6
- URN
-
urn:nbn:de:101:1-2022082921364542042928
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ibrahim, Sherihan Salaheldin Abdelhamid
- El-Aal, Sarah A. Abd
- Reda, Ahmed M.
- Achy, Samar El
- Shahine, Yasmine
- SpringerLink (Online service)
Other Objects (12)
Analysis of apoptosis related genes in nurses exposed to anti-neoplastic drugs
New anti-neoplastic drug test using in vitro model: what to be concern?
Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers
Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis
Antineoplastic chemotherapy
The anti-neoplastic effect of doxycycline in osteosarcoma as a metalloproteinase (MMP) inhibitor: a systematic review
Early Systemic Anti-neoplastic Treatment Post SARS-CoV-2 Infection in Patients with Breast Cancer
Anti-neoplastic sulfonamides alter the metabolic homeostasis and disrupt the suppressor activity of regulatory T cells
Multiple outcomes for PI3K/Akt/mTOR targeting in non-Hodgkin lymphoma
Targeting the Hedgehog and PI3K/AKT/mTOR signaling pathways in rhabdomyosarcoma
Angelica Sinensis promotes myotube hypertrophy through the PI3K/Akt/mTOR pathway
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
Analysis of apoptosis related genes in nurses exposed to anti-neoplastic drugs
New anti-neoplastic drug test using in vitro model: what to be concern?
Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers
Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis
Antineoplastic chemotherapy
The anti-neoplastic effect of doxycycline in osteosarcoma as a metalloproteinase (MMP) inhibitor: a systematic review
Early Systemic Anti-neoplastic Treatment Post SARS-CoV-2 Infection in Patients with Breast Cancer
Anti-neoplastic sulfonamides alter the metabolic homeostasis and disrupt the suppressor activity of regulatory T cells
Multiple outcomes for PI3K/Akt/mTOR targeting in non-Hodgkin lymphoma
Targeting the Hedgehog and PI3K/AKT/mTOR signaling pathways in rhabdomyosarcoma
Angelica Sinensis promotes myotube hypertrophy through the PI3K/Akt/mTOR pathway
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
Analysis of apoptosis related genes in nurses exposed to anti-neoplastic drugs
New anti-neoplastic drug test using in vitro model: what to be concern?
Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers
Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis
Antineoplastic chemotherapy
The anti-neoplastic effect of doxycycline in osteosarcoma as a metalloproteinase (MMP) inhibitor: a systematic review
Early Systemic Anti-neoplastic Treatment Post SARS-CoV-2 Infection in Patients with Breast Cancer
Anti-neoplastic sulfonamides alter the metabolic homeostasis and disrupt the suppressor activity of regulatory T cells
Multiple outcomes for PI3K/Akt/mTOR targeting in non-Hodgkin lymphoma
Targeting the Hedgehog and PI3K/AKT/mTOR signaling pathways in rhabdomyosarcoma
Angelica Sinensis promotes myotube hypertrophy through the PI3K/Akt/mTOR pathway